✦ LIBER ✦

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy

✍ Scribed by Junichi Hasegawa; Tatsuo Kanda; Seiichi Hirota; Masafumi Fukuda; Akiko Nishitani; Tsuyoshi Takahashi; Isao Kurosaki; Shusaku Tsutsui; Katsuyoshi Hatakeyama; Toshirou Nishida

Publisher: Springer
Year: 2007
Tongue: English
Weight: 224 KB
Volume: 12
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-007-0657-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic therapy for advanced gastrointe

Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib

✍ Edward J. Kim; Mark M. Zalupski 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract Progression on first‐line therapy with imatinib in gastrointestinal stromal tumors (GIST) is caused by either initial resistance or more often a secondary mutation in tyrosine kinases KIT or PDGFR. Therapies in development for imatinib‐resistant GIST include agents that target KIT/PDGFR

Surgical intervention for imatinib and s

Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors

✍ Hirotoshi Kikuchi; Tomohiko Setoguchi; Shinichiro Miyazaki; Masayoshi Yamamoto; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 593 KB

Surgical intervention following imatinib

Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs)

✍ Sun Jin Sym; Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae-Won Kim; Hee Cheol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Surgical treatment of patients with init

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

✍ Piotr Rutkowski; Zbigniew Nowecki; Pawel Nyckowski; Wirginiusz Dziewirski; Urszu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Focal progression in patients with gastr

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients

✍ Salah-Eddin Al-Batran; Joerg Thomas Hartmann; Florian Heidel; Jan Stoehlmacher; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 326 KB

A successful case of oral molecularly ta

A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor

✍ Tatsuo Kanda; Manabu Ohashi; Shigeto Makino; Kouji Kaneko; Atsushi Matsuki; Sato 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 395 KB